✦ LIBER ✦

848-3 Estrogen plus progestin and the risk of peripheral arterial disease

✍ Scribed by Judith Hsia; Michael Criqui; Rebecca Rodabough; Helaine Resnick; Jane Kotchen; Denise Bonds; Matt Allison; Pat Caralis; Lawrence Phillips; Kamal Masaki; Robert D Langer

Book ID: 119549799
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 66 KB
Volume: 43
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(04)92185-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Estrogen plus progestin and risk of coro

Estrogen plus progestin and risk of coronary heart disease

✍ J.E. Manson 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 31 KB

Estrogen plus progestin and the risk of

Estrogen plus progestin and the risk of coronary heart disease

✍ J.E. Manson; J. Hsia; K.C. Johnson 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 33 KB

Postmenopausal estrogen and progestin us

Postmenopausal estrogen and progestin use and the risk of cardiovascular disease

✍ F. Grodstein; M.J. Stampfer; J.E. Manson; G.A. Colditz; W.C. Willett; B. Rosner; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Conjugated equine estrogens and peripher

Conjugated equine estrogens and peripheral arterial disease risk: The Women's Health Initiative

✍ Judith Hsia; Michael H. Criqui; David M. Herrington; JoAnn E. Manson; LieLing Wu 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 306 KB

2–3 Prior hormone therapy and breast can

2–3 Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin

✍ Vassilopoulou-Sellin, R. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Prior hormone therapy and breast cancer

Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin

✍ Garnet L. Anderson; Rowan T. Chlebowski; Jacques E. Rossouw; Rebecca J. Rodaboug 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 401 KB